Clinical Trial Update: KK-LC-1 TCR-T Cell Therapy for Gastric, Breast, Cervical, and Lung Cancer [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update for KK-LC-1-targeted TCR-T cell therapy across gastric, breast, cervical, and lung cancers; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Cervical Cancer
• Gastric Cancer
• Lung Cancer

Drugs mentioned

• KK-LC-1 TCR-T Cell Therapy (KK-LC-1-targeted TCR-T cell therapy)

Snippet

Sponsor: Christian Hinrichs | Conditions: Gastric Cancer, Breast Cancer | Phase 1 | Status: RECRUITING